M55 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - MacroGenics Inc

Watchlist Manager

Watchlist

Price: 3.22 EUR -4.17% Market Closed

Market Cap: €199.7m

M	MacroGenics Inc SWB:M55	US
T	Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd SGX:T14	CN
	Also Holding AG F:9AS	CH
N	Neogenomics Inc F:NG9	US

Profitability Summary

MacroGenics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

76%

Negative Operating Margin

-24%

Negative 3Y Average Operating Margin

-112%

Operating Margin is Increasing

-88% > -24%

Negative Net Margin

-9%

Negative 3Y Average Net Margin

-67%

Declining Net Margin

41% > -9%

Negative Free Cash Flow Margin

-39%

Negative 3Y Average Free Cash Flow Margin

-112%

Declining Free Cash Flow Margin

-18% > -39%

Negative ROE

-33%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-131%

ROIC is Increasing

-145% > -35%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

76%

Negative Operating Margin

-24%

Negative 3Y Average Operating Margin

-112%

Operating Margin is Increasing

-88% > -24%

Negative Net Margin

-9%

Negative 3Y Average Net Margin